公开(公告)号：US20190021596A1

公开(公告)日：2019-01-24

申请号：US16137411

申请日：2018-09-20

Applicant: DexCom, Inc.

Inventor： Mark Brister ,  Paul V. Neale ,  Peter C. Simpson ,  James H. Brauker ,  James Patrick Thrower ,  Mark Shults ,  Rathbun K. Rhodes ,  Paul V. Goode, JR. ,  Arnold L. Holmquist

IPC: A61B5/00 ,  A61B5/1473 ,  A61B5/145 ,  A61B5/07

Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.

公开(公告)号：US09833143B2

公开(公告)日：2017-12-05

申请号：US14296735

申请日：2014-06-05

Applicant: DexCom, Inc.

Inventor： Mark Brister ,  Paul V. Neale ,  Peter C. Simpson ,  James H. Brauker ,  James Patrick Thrower ,  Mark Shults ,  Rathbun K. Rhodes ,  Paul V. Goode, Jr. ,  Arnold L. Holmquist

IPC: A61B5/1473 ,  H04B1/03 ,  A61B5/00 ,  A61B5/07 ,  A61B5/145

CPC classification number: A61B5/0015 ,  A61B5/0031 ,  A61B5/076 ,  A61B5/14532 ,  A61B5/14546 ,  A61B5/1473 ,  A61B2560/04 ,  A61B2560/0462 ,  A61B2562/247 ,  H04B1/03

Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.

公开(公告)号：US20210369114A1

公开(公告)日：2021-12-02

申请号：US17143946

申请日：2021-01-07

Applicant: DexCom, Inc.

Inventor： Mark Brister ,  Paul V. Neale ,  Peter C. Simpson ,  James H. Brauker ,  James Patrick Thrower ,  Mark Shults ,  Rathbun K. Rhodes ,  Paul V. Goode, JR. ,  Arnold L. Holmquist

IPC: A61B5/00 ,  A61B5/07 ,  A61B5/145 ,  A61B5/1473

Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.

公开(公告)号：US20140288403A1

公开(公告)日：2014-09-25

申请号：US14296735

申请日：2014-06-05

Applicant: DexCom, Inc.

Inventor： Mark Brister ,  Paul V. Neale ,  Peter C. Simpson ,  James H. Brauker ,  James Patrick Thrower ,  Mark Shults ,  Rathbun K. Rhodes ,  Paul V. Goode ,  Arnold L. Holmquist

IPC: A61B5/145 ,  A61B5/00

CPC classification number: A61B5/0015 ,  A61B5/0031 ,  A61B5/076 ,  A61B5/14532 ,  A61B5/14546 ,  A61B5/1473 ,  A61B2560/04 ,  A61B2560/0462 ,  A61B2562/247 ,  H04B1/03

Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.

公开(公告)号：US10327638B2

公开(公告)日：2019-06-25

申请号：US15798097

申请日：2017-10-30

Applicant: DexCom, Inc.

Inventor： Mark C. Brister ,  Paul V. Neale ,  Peter C. Simpson ,  James H. Brauker ,  James Patrick Thrower ,  Mark Shults ,  Rathbun K. Rhodes ,  Paul V. Goode, Jr. ,  Arnold L. Holmquist

IPC: A61B5/1473 ,  A61B5/1468 ,  A61B5/00 ,  A61B5/07 ,  A61B5/145 ,  H04B1/03

Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.

公开(公告)号：US09757061B2

公开(公告)日：2017-09-12

申请号：US14842276

申请日：2015-09-01

Applicant: DexCom, Inc.

Inventor： Mark Shults ,  Rathbun K. Rhodes ,  Stuart J. Updike ,  James H. Brauker

IPC: A61B5/05 ,  A61B5/1486 ,  A61B5/145

CPC classification number: A61B5/14532 ,  A61B5/0002 ,  A61B5/0031 ,  A61B5/145 ,  A61B5/14503 ,  A61B5/14865 ,  A61B5/1495 ,  A61B5/150022 ,  A61B5/6846

Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous and subcutaneous measurement of glucose in a host.

公开(公告)号：US20140275900A1

公开(公告)日：2014-09-18

申请号：US14290842

申请日：2014-05-29

Applicant: DexCom, Inc.

Inventor： Mark Shults ,  James H. Brauker ,  Victoria Carr-Brendel ,  Mark Tapsak ,  Dubravka Markovic

IPC: A61B5/1486 ,  A61B5/145

CPC classification number: A61B5/14865 ,  A61B5/14532 ,  A61L31/10 ,  A61L31/14 ,  A61L31/146 ,  A61L31/16 ,  A61L2300/00 ,  B33Y80/00 ,  G01N33/48707

Abstract: A biointerface membrane for an implantable device including a nonresorbable solid portion with a plurality of interconnected cavities therein adapted to support tissue ingrowth in vivo, and a bioactive agent incorporated into the biointerface membrane and adapted to modify the tissue response is provided. The bioactive agents can be chosen to induce vascularization and/or prevent barrier cell layer formation in vivo, and are advantageous when used with implantable devices wherein solutes are transported across the device-tissue interface.

Abstract translation: 一种用于可植入装置的生物界面膜，其包括不可再吸收的固体部分，其具有适于在体内支持组织向内生长的多个相互连接的空腔，以及并入生物界面膜中并适于修饰组织反应的生物活性剂。 可以选择生物活性剂以诱导血管形成和/或预防体内阻隔细胞层形成，并且当与其中溶质被输送穿过装置 - 组织界面的可植入装置一起使用时是有利的。

公开(公告)号：US20240180462A1

公开(公告)日：2024-06-06

申请号：US18405518

申请日：2024-01-05

Applicant: Dexcom, Inc.

Inventor： James H Brauker ,  Robert J. Boock ,  Monica Rixman Swinney ,  Peter C. Simpson ,  Mark C. Brister ,  Mark Shults

IPC: A61B5/1486 ,  A61B5/00 ,  A61B5/145 ,  A61B5/1473 ,  C12Q1/00 ,  G01N33/543 ,  G01N33/66

CPC classification number: A61B5/14865 ,  A61B5/14532 ,  A61B5/411 ,  A61B5/6848 ,  C12Q1/006 ,  G01N33/54366 ,  G01N33/66 ,  A61B5/1473 ,  A61B5/418 ,  A61B2562/08 ,  Y02A50/30

Abstract: Biointerface membranes are provided which can be utilized with implantable devices, such as devices for the detection of analyte concentrations in a biological sample. More particularly, methods for monitoring glucose levels in a biological fluid sample using an implantable analyte detection device incorporating such membranes are provided.

公开(公告)号：US20230301558A1

公开(公告)日：2023-09-28

申请号：US18176301

申请日：2023-02-28

Applicant: Dexcom, Inc.

Inventor： Mark Shults ,  Rathbun Rhodes ,  Stuart Updike ,  James H. Brauker

IPC: A61B5/145 ,  A61B5/1486 ,  A61B5/00 ,  A61B5/1495 ,  A61B5/15

CPC classification number: A61B5/14532 ,  A61B5/14865 ,  A61B5/0002 ,  A61B5/0031 ,  A61B5/145 ,  A61B5/14503 ,  A61B5/1495 ,  A61B5/150022 ,  A61B5/6846

Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous and subcutaneous measurement of glucose in a host.

公开(公告)号：US20200375515A1

公开(公告)日：2020-12-03

申请号：US16998841

申请日：2020-08-20

Applicant: DexCom, Inc.

Inventor： Mark Shults ,  James H. Brauker ,  Victoria Carr-Brendel ,  Mark Tapsak ,  Dubravka Markovic

IPC: A61B5/1486 ,  A61B5/145 ,  A61L31/10 ,  A61L31/14 ,  A61L31/16

Abstract: A biointerface membrane for an implantable device including a nonresorbable solid portion with a plurality of interconnected cavities therein adapted to support tissue ingrowth in vivo, and a bioactive agent incorporated into the biointerface membrane and adapted to modify the tissue response is provided. The bioactive agents can be chosen to induce vascularization and/or prevent barrier cell layer formation in vivo, and are advantageous when used with implantable devices wherein solutes are transported across the device-tissue interface.